Literature DB >> 19673626

Management of acute severe ulcerative colitis.

Glen A Doherty1, Adam S Cheifetz.   

Abstract

Ulcerative colitis is a chronic relapsing and remitting inflammatory disorder that can generally be managed successfully with maintenance oral medications. However, approximately 15% of patients with ulcerative colitis will develop a severe exacerbation and require hospitalization. While many patients with acute severe ulcerative colitis will respond to a short course of intravenous corticosteroids, up to a third will fail to improve. In these patients with steroid-refractory colitis, the choice is between rescue medical therapy with ciclosporin or infliximab, or surgery. Well-timed rescue medical therapy is generally safe when administered by experienced physicians, and is effective in the majority of cases. Surgery is unavoidable in some cases, but is the treatment of choice in others. While ileal pouch-anal anastomosis offers the prospect of life without a permanent ileostomy, there are issues with its long-term functional outcome.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19673626     DOI: 10.1586/egh.09.24

Source DB:  PubMed          Journal:  Expert Rev Gastroenterol Hepatol        ISSN: 1747-4124            Impact factor:   3.869


  5 in total

Review 1.  Glucocorticoid receptor modulates dendritic cell function in ulcerative colitis.

Authors:  Xinxin Yang; Jingshu Geng; Hongxue Meng
Journal:  Histol Histopathol       Date:  2020-07-24       Impact factor: 2.303

2.  Contraceptive method selection by women with inflammatory bowel diseases: a cross-sectional survey.

Authors:  Lori M Gawron; Andrew J Gawron; Amanda Kasper; Cassing Hammond; Laurie Keefer
Journal:  Contraception       Date:  2014-01-07       Impact factor: 3.375

3.  Outcomes for Ulcerative Colitis With Delayed Emergency Colectomy Are Worse When Controlling for Preoperative Risk Factors.

Authors:  Ira L Leeds; Margaret H Sundel; Alodia Gabre-Kidan; Bashar Safar; Brindusa Truta; Jonathan E Efron; Sandy H Fang
Journal:  Dis Colon Rectum       Date:  2019-05       Impact factor: 4.585

Review 4.  New developments in ulcerative colitis: latest evidence on management, treatment, and maintenance.

Authors:  Kartikeya Tripathi; Joseph D Feuerstein
Journal:  Drugs Context       Date:  2019-04-29

Review 5.  The impact of pre-operative biologic therapy on post-operative surgical outcomes in ulcerative colitis: a systematic review and meta-analysis.

Authors:  Jasmine Zanelli; Subashini Chandrapalan; Abhilasha Patel; Ramesh P Arasaradnam
Journal:  Therap Adv Gastroenterol       Date:  2020-08-18       Impact factor: 4.409

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.